Association Between Newborn Thyroid-Stimulating-Hormone Concentration and Neurodevelopment and Growth: a Systematic Review.

Biol Trace Elem Res

Department of Food and Nutrition, School of Agriculture Food and Wine, The University of Adelaide, PMB1, Glen Osmond, 5064, SA, Australia.

Published: February 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Iodine nutrition during pregnancy can affect newborn thyroid-stimulating-hormone concentration (TSH). Associations of newborn TSH with the neurodevelopment and growth of children are inconsistent. The aim of the study was to systematically review the literature on the associations between newborn TSH and childhood neurodevelopment and growth. Databases including PubMed, Scopus, CINAHL, Embase, PsycINFO, WHO, and Iodine Global Network were searched for eligible studies. Seventeen studies were included. Neurodevelopment was assessed using different tools in children aged 1-12 years of age. The associations between newborn TSH and cognitive development were negative in studies from iodine deficient populations, while a null association was found in studies from iodine sufficient populations. A null association between TSH and psychomotor development was observed regardless of iodine status of the study populations. There was no evidence of an association between newborn TSH and child anthropometry, but evidence of negative association was found between newborn TSH and birthweight. Although the associations between newborn TSH and neurodevelopment may differ based on the iodine status of populations, most of the included studies did not adjust for the key confounders and had a small sample size. Quality data-linkage studies that utilize newborn TSH data from newborn screening with adequate adjustment for potential confounders are warranted to better understand the relationship between newborn TSH and neurodevelopment and growth in children. CRD42020152878.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12011-021-02665-7DOI Listing

Publication Analysis

Top Keywords

newborn tsh
32
neurodevelopment growth
16
associations newborn
16
association newborn
12
tsh neurodevelopment
12
newborn
10
tsh
10
newborn thyroid-stimulating-hormone
8
thyroid-stimulating-hormone concentration
8
growth children
8

Similar Publications

Hypothyroidism is most frequently caused by Hashimoto's thyroiditis. While thyrotropin receptor antibodies are well-known in Graves' disease-induced hyperthyroidism, their role in hypothyroidism is emerging. We report the case of a 37-year-old woman with facial and periorbital edema, weight gain, and hoarseness suggestive of hypothyroidism.

View Article and Find Full Text PDF

Objective: Gestational diabetes mellitus (GDM) affects maternal-fetal metabolism, but its impact on neonatal thyroid function remains unclear. This study aimed to evaluate the association between maternal GDM and total thyroxine (TT4) levels in newborn screening (NBS) and to identify contributing maternal and neonatal factors.

Methods: This observational cohort study linked national NBS thyroid data with hospital medical records.

View Article and Find Full Text PDF

Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder. It is one of the clinical conditions that has benefited most from the introduction of newborn screening 50 years ago, as clinical management has changed and long-term consequences have been significantly reduced. In areas where neonatal screening is active, most affected patients show a clinically normal phenotype and/or only mild symptoms.

View Article and Find Full Text PDF

Congenital hypothyroidism (CH) is a heterogeneous condition present at birth, resulting in severe-to-mild thyroid hormone deficiency. This condition is difficult to recognize shortly after birth. Therefore, many countries worldwide have implemented newborn screening (NBS) programs for CH since the 1970s.

View Article and Find Full Text PDF

Congenital hypothyroidism (CH) is a leading preventable cause of neurocognitive impairment. Its incidence appears to be rising in several countries. We analysed 27 years of newborn-screening data (1997-2023) from the largest Chilean screening centre, covering 3,225,216 newborns (51.

View Article and Find Full Text PDF